Skip to main content

$3.86 Million NIH Grant Accelerates Purdue Veterinary Scholar’s Novel Approach in Race to Develop Effective Vaccine to Combat COVID-19

Suresh Mittal pictured standing in front of the Continuum sculpture outside Lynn Hall

In the midst of the COVID-19 pandemic, with many schools and colleges across the United States implementing plans to start face-to-face classroom teaching, the race to develop an effective vaccine is intensifying, according to Purdue University Distinguished Professor of Virology Suresh Mittal. “The availability of an effective vaccine will be vital to protect everyone here in the U.S. and worldwide,” said Dr. Mittal, who is an accomplished vaccine researcher in the College of Veterinary Medicine’s Department of Comparative Pathobiology. 

COVID-19 is caused by a coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Dr. Mittal is leading a research team that is taking a novel approach to developing an efficient vaccine for COVID-19, and the research just received a major boost in the form of a five-year $3.86 million grant from the National Institutes of Health.  

Dr. Mittal’s approach utilizes a harmless form of a common cold-like adenovirus as a vaccine platform. “This platform-based vaccine expresses the important SARS-CoV-2 immunogens that produce an immune response,” Dr. Mittal said. “This type of COVID-19 vaccine provides a balanced antibody and cell-based protection.”

Dr. Mittal said the COVID-19 vaccine needs to be highly immunogenic because the human immune system does not have an immune memory against this new virus.  His vaccine approach is simple due to the use of a safe version of adenovirus with the capability to induce protective immune responses.

Dr. Mittal is collaborating on the research with Dr. Suresh Kuchipudi, clinical professor and associate director of the Animal Diagnostic Laboratory at Pennsylvania State University; and Dr. Suryaprakash Sambhara, Immunology Laboratory team lead at the Influenza Division of the Centers for Disease Control and Prevention.

Dr. Mittal emphasized that it will be critical to have several vaccine approaches in order to meet global demand for the COVID-19 vaccine. He said at present, there are at least three adenovirus-based COVID-19 vaccines in Phase 2 or 3 clinical trials. More than 160 COVID-19 vaccines are at various stages of development.

Dr. Mittal also cautions that the elderly are the most vulnerable segment of the population because of a higher risk of COVID-19 severity, and therefore, vaccine development efforts should consider the decline in the immune competence of the elderly. 

“An effective COVID-19 vaccine will flatten the COVID-19 pandemic’s trajectory and its second wave, thus saving lives and the global economy,” Dr. Mittal said.

Writer(s): Kevin Doerr | pvmnews@purdue.edu

Recent Stories

DVM and Veterinary Technology students gain job opportunity insights at fall PVM Career Fair

Purdue Veterinary Medicine's Fall Career Fair brought veterinary and veterinary technology students together with employers on October 30 at the Purdue Memorial Union. Students explored career opportunities, internships and externships while meeting representatives from veterinary practices and organizations.

In Memory: Dr. Mary Beth Leininger (PU DVM ’67)

Purdue Veterinary Medicine remembers Dr. Mary Beth Leininger (DVM 1967), who died November 6, 2026, at age 83. The first woman elected president of the American Veterinary Medical Association, she spent nearly three decades in private practice and held leadership positions in veterinary medicine, industry and education.

“Paws Up” for Kayla Fuqua – brought to you by the PVM Wellness Committee

Kayla Fuqua, the day-shift Emergency and Critical Care receptionist at our veterinary hospital, is this week's Paws Up honoree. A colleague recognized her for supporting clients, coworkers and veterinary students, answering questions and helping her department during busy shifts.

MMAS Symposium at Purdue provides hands-on learning about Medicine of Mammalian and Avian Species

More than 80 participants joined Purdue Veterinary Medicine's 2026 Medicine of Mammalian and Avian Species Symposium on October 31 and November 1. Organized by the Exotic Animal Club, the two-day event combined presentations on exotic animal medicine with hands-on training in parrot handling, rabbit examinations, avian clinical pathology and other specialized topics.

Costumed characters boost Halloween spirits in Lynn Hall

Halloween brought Minions, the Lorax, Super Mario Bros. characters and plenty of other costumes to Purdue Veterinary Medicine. Students, faculty and staff celebrated with costume contests, trick-or-treating and a Halloween dessert competition in Lynn Hall, the Reed ADDL and the Veterinary Hospital.